Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-31 @ 3:10 AM
Study NCT ID:
NCT01772004
Status:
COMPLETED
Last Update Posted:
2021-12-20
First Post:
2013-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Solid Tumors | View |
| None | MSB0010718C | View |
| None | Phase 1 | View |
| None | Pharmacokinetic | View |
| None | anti PD-L1 | View |
| None | Non-small cell lung cancer (NSCLC) | View |
| None | Metastatic breast cancer (MBC) | View |
| None | Gastric and gastroesophageal junction (GEJ) cancer | View |
| None | Ovarian cancer | View |
| None | Colorectal cancer (CRC) | View |
| None | Castrate-resistant prostate cancer (CRPC) | View |
| None | Melanoma | View |
| None | Urothelial carcinoma | View |
| None | Bladder cancer | View |
| None | Head and neck squamous cell carcinoma (HNSCC) | View |
| None | Renal cell carcinoma (RCC) | View |
| None | Adrenocortical carcinoma (ACC) | View |